NDC 80425-0209-04 - Celecoxib
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0209
- Requested NDC
- 80425-0209-04
- Package NDCs from labels
- 80425-0209-1, 80425-0209-2, 80425-0209-4, 80425-0209-3, 80425-0209-5, 80425-0209-04
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2026-03-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Celecoxib - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2026-03-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0209-1 | Celecoxib | 30 in 1 BOTTLE | CAPSULE | 30 | 7 | |
| 80425-0209-2 | Celecoxib | 60 in 1 BOTTLE | CAPSULE | 60 | 7 | |
| 80425-0209-3 | Celecoxib | 90 in 1 BOTTLE | CAPSULE | 90 | 7 | |
| 80425-0209-4 | Celecoxib | 180 in 1 BOTTLE | CAPSULE | 180 | 7 | |
| 80425-0209-5 | Celecoxib | 6 in 1 BOTTLE | CAPSULE | 6 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0209 | CELECOXIB CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 6 | Current NDC, Legacy NDC, 5 package rows | 20250101_eca923da-59fa-da2e-e053-2a95a90a6a51.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0209-1 | EA - Each | 80425-0209 | 7501609c-9573-4e42-916d-78f217259cb9 | 1 | 2023-03-13 |
| 80425-0209-2 | EA - Each | 80425-0209 | e52284e1-51e9-4784-b1cb-fa70b460ea8e | 1 | 2023-03-13 |
| 80425-0209-3 | EA - Each | 80425-0209 | 199230fd-ac65-4faf-b1ac-4165d84f8282 | 1 | 2023-03-13 |
| 80425-0209-4 | EA - Each | 80425-0209 | b6878fc7-9624-4c69-92fe-d17ba0f89205 | 1 | 2023-03-13 |
| 80425-0209-5 | EA - Each | 80425-0209 | da106ad5-bfd2-4fa8-93f6-0dbab70d5a4b | 1 | 2026-04-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Celecoxib | CELECOXIB | Direct_Rx | 4b2ffbdb-1847-d93b-e063-6394a90a06f5 | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | ANDA210071 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Unichem Pharmaceuticals (USA), Inc. | 0e8484a8-04a6-4be3-8c5c-1883b0490d53 | 2026-10-30 | Boxed warning, Warnings, Adverse reactions | 205323 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Direct_Rx | 5eff2336-7e06-d5ca-e063-6394a90aa3c7 | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | ANDA210071 205323 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | NIVAGEN PHARMACEUTICALS, INC. | ae7943ab-b1fc-f08f-e053-2995a90a051e | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 205323 205322 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | Umedica Laboratories USA Inc. | b0e0243e-59b3-4f73-8c21-86b60fc7894b | 2026-10-23 | Boxed warning, Warnings, Adverse reactions | 205323 205322 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | REMEDYREPACK INC. | d0ca85fa-8b80-4a48-a1a4-a1c181821c39 | 2026-10-12 | Boxed warning, Warnings, Adverse reactions | 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | A-S Medication Solutions | 578415f8-75c5-46fa-95e9-c7eb911eeb7d | 2026-10-09 | Boxed warning, Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Celecoxib | CELECOXIB | REMEDYREPACK INC. | f5d0e5b9-97d8-42a4-a0a0-c09dde7008e6 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | ANDA210071 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | St. Mary's Medical Park Pharmacy | 57b07096-6d7c-1653-e063-6294a90aa6e2 | 2026-10-02 | Boxed warning, Warnings, Adverse reactions | ANDA210071 205323 JCX84Q7J1L |
| Celecoxib | CELECOXIB | A-S Medication Solutions | dea035a6-dcf1-4b7d-8adc-a2f678b71fd9 | 2026-09-29 | Boxed warning, Warnings, Adverse reactions | ANDA210071 205323 JCX84Q7J1L |
| celecoxib | CELECOXIB | Asclemed USA, Inc. | f6291230-7598-407a-aef0-ec1f09277d2a | 2026-09-25 | Boxed warning, Warnings, Adverse reactions | 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | REMEDYREPACK INC. | 7de31e90-2eaf-46cd-a058-3946b029d88c | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | ANDA210071 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Direct_Rx | 59cca611-c035-da50-e063-6294a90a73f5 | 2026-09-15 | Boxed warning, Warnings, Adverse reactions | ANDA210071 205322 JCX84Q7J1L |
| CELECOXIB | CELECOXIB | American Health Packaging | 4af52ae3-6b9d-4bc9-ad6b-c983e4c9dcc7 | 2026-09-08 | Boxed warning, Warnings, Adverse reactions | 205323 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Major Pharmaceuticals | 3a1eadd5-c0a7-473e-bde0-6b9450d11c95 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 205323 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | REMEDYREPACK INC. | c96509cc-47f4-44f8-9f7e-4e49cc3d5348 | 2026-08-28 | Boxed warning, Warnings, Adverse reactions | ANDA210071 205323 JCX84Q7J1L |
| Celecoxib | CELECOXIB | DirectRx | e0f3aacf-df5d-dad7-e053-2995a90ac5eb | 2026-08-27 | Warnings, Adverse reactions | 205323 JCX84Q7J1L |
| Celecoxib | CELECOXIB | A-S Medication Solutions | e84d67c8-010d-495c-8691-ae16d0698f8d | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | ANDA210071 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | St. Mary's Medical Park Pharmacy | 59f495e8-3cea-9d98-e063-6394a90a89d4 | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | 205322 JCX84Q7J1L |
| Celecoxib | CELECOXIB | Mullan Pharmaceutical Inc. | 643e177f-216d-4dfa-824a-7516a488304e | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | ANDA210071 205323 205322 JCX84Q7J1L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.